CollectionsJohnson Johnson
IN THE NEWS

Johnson Johnson

FEATURED ARTICLES
BUSINESS
February 26, 2015 | By David Sell, Inquirer Staff Writer
A Philadelphia jury said Tuesday that drugmaker Johnson & Johnson should pay $2.5 million to a 20-year-old autistic man from Alabama - who developed size 46 DD breasts as a young teenager - because the company failed to adequately warn of that potential side effect from his use of the antipsychotic drug Risperdal. This was the first case related to the condition called gynecomastia that went to a jury, but thousands more lawsuits are lined up in Philadelphia, California, Missouri, and other locations.
NEWS
May 11, 1998 | By Thomas J. Brady, INQUIRER STAFF WRITER
M. Gail Judge, 62, a Johnson & Johnson executive, died of cancer at her home in Yardley on Saturday. Ms. Judge had a 26-year career with Johnson & Johnson, serving as vice president of human resources for McNeil Pharmaceutical in Spring House, Pa., where she also was a member of the management board. Her most recent position was as director of corporate management training and development. Before joining Johnson & Johnson, she was a member of the Sisters of Mercy and taught at Georgian Court College, Notre Dame High School in Lawrenceville, and Cathedral High School in Trenton.
SPORTS
April 19, 1999 | Daily News Wire Services
Johnson & Johnson became the first sponsor to abandon the scandal-ridden Olympics, backing off an estimated $30 million deal for the 2002 Winter Games. Company spokesman John McKeegan yesterday blamed the decision on internal disagreements about how to link the company's many brands under a sponsorship umbrella in time for the Salt Lake City Games. But he acknowledged that Olympic bribery was a factor. "We can't say that it didn't have anything to do with it," McKeegan said.
BUSINESS
July 1, 1989 | By Richard Burke, Inquirer Staff Writer
A federal jury in Philadelphia yesterday awarded almost $8 million in damages to Advanced Medical Inc. after finding that the Horsham company had lost a contract to distribute medical equipment because of interference by Johnson & Johnson and several subsidiaries. A U.S. District Court jury of five women and four men deliberated less than an hour and a half over two days before returning the verdict in favor of Advanced Medical. The case involved a 1986 contract between Advanced Medical and Arden Medical Inc. of Minneapolis, later bought by Johnson & Johnson.
BUSINESS
September 1, 2012 | By David Sell, Inquirer Staff Writer
Thirty-six states and the District of Columbia will share in $181 million that Johnson & Johnson has agreed to pay to resolve allegations of inappropriate marketing of the antipsychotic drug Risperdal. Pennsylvania, New Jersey, and Delaware are among the states that filed similar complaints in their own courts Thursday and will get $8.4 million, $5.3 million, and $4.2 million, respectively. New York will get $9 million. Johnson & Johnson has headquarters in New Brunswick, N.J.; its Janssen Pharmaceuticals subsidiary, which makes Risperdal, is based in Titusville.
BUSINESS
February 22, 2012 | By David Sell, Inquirer Staff Writer
Johnson & Johnson chief executive officer Bill Weldon, 63, will retire in April, after a string of product recalls that have embarrassed the health-care giant in recent years. Alex Gorsky, 51, one of two vice chairmen, will succeed Weldon at the company's annual meeting. Gorsky edged out fellow vice chair Sheri McCoy for the top spot with the company, which had $65 billion in sales with such names as Band-Aids and Tylenol, along with medical devices and pharmaceuticals. The last big acquisition on Weldon's watch - and one of the biggest in health care in 2011 - was the as-yet-unfinalized $21.3 billion takeover of the medical-device manufacturer Synthes Inc., which has operations in Chester County.
NEWS
July 21, 2010 | By Christopher K. Hepp, INQUIRER STAFF WRITER
Just a month after a top executive of Johnson & Johnson promised a "cooperative and transparent dialogue" with the Food and Drug Administration, FDA inspectors found themselves stymied when seeking records at J&J's Lancaster plant. According to an inspection report for the plant released Wednesday by the FDA, inspectors said they were confronted by numerous delays when seeking records concerning drug production and controls. Even something as basic as an organizational chart for the plant was not readily available, according to the report.
NEWS
October 22, 2013 | BY JOHN F. MORRISON, Daily News Staff Writer morrisj@phillynews.com, 215-854-5573
BACK IN 1982, the nation was terrorized by the Tylenol poison scare. Although the fatal poisonings of seven people, including a 12-year-old girl, from taking cyanide-laced Extra-Strength Tylenol capsules were confined to the Chicago area, repercussions were felt everywhere. Johnson & Johnson, parent company of McNeil Consumer Healthcare, the drug's manufacturer, pulled 32 million packages of Tylenol off the shelves of stores throughout the nation, taking a huge nose-dive in profits as a result.
BUSINESS
January 22, 2003 | By Linda Loyd INQUIRER STAFF WRITER
Johnson & Johnson said yesterday that net earnings climbed 17 percent last year, helped by demand for products ranging from its Remicade arthritis medication to a treatment for anemia. Fourth-quarter profit surged 30 percent, boosted by robust sales of medical devices for the heart and prescription drugs, including Remicade, which is manufactured by Centocor Inc., a J&J subsidiary in Malvern. "It's as impressive as it gets," Morningstar Inc. analyst Todd Lebor said. "What's most impressive is the jump in operating margin.
1 | 2 | 3 | 4 | 5 | Next »
ARTICLES BY DATE
BUSINESS
February 26, 2015 | By David Sell, Inquirer Staff Writer
A Philadelphia jury said Tuesday that drugmaker Johnson & Johnson should pay $2.5 million to a 20-year-old autistic man from Alabama - who developed size 46 DD breasts as a young teenager - because the company failed to adequately warn of that potential side effect from his use of the antipsychotic drug Risperdal. This was the first case related to the condition called gynecomastia that went to a jury, but thousands more lawsuits are lined up in Philadelphia, California, Missouri, and other locations.
BUSINESS
January 22, 2015 | By David Sell, Inquirer Staff Writer
Johnson & Johnson has been a long-term moneymaker, and it said Tuesday that its full-year profit for 2014 rose 18 percent, but the last few months were less profitable for the health-care giant. And it forecast declining profits in the near term because of price pressure on big-ticket drugs, stretched consumers, and tumult in world currency markets. Though consumer products are the smallest of its three divisions, the tumult in Fort Washington, site of the headquarters of J&J's McNeil Consumer Healthcare unit, might finally be nearing a regulatory end. But then, previous target dates have come and gone.
NEWS
October 22, 2013 | BY JOHN F. MORRISON, Daily News Staff Writer morrisj@phillynews.com, 215-854-5573
BACK IN 1982, the nation was terrorized by the Tylenol poison scare. Although the fatal poisonings of seven people, including a 12-year-old girl, from taking cyanide-laced Extra-Strength Tylenol capsules were confined to the Chicago area, repercussions were felt everywhere. Johnson & Johnson, parent company of McNeil Consumer Healthcare, the drug's manufacturer, pulled 32 million packages of Tylenol off the shelves of stores throughout the nation, taking a huge nose-dive in profits as a result.
BUSINESS
March 12, 2013
New Jersey employers who hire and train former pharmaceutical workers can receive training grants of up to $14,000 per worker over six months, the New Jersey Department of Labor and Workforce Development announced Monday. Employers from all industries can participate, but the program will only cover former employees from approved locations of Bristol-Myers Squibb, Hoffman-La Roche, Johnson & Johnson, Merck & Co., and Pfizer. The state received the federal grant that underwrites this program in October 2010.
BUSINESS
March 6, 2013 | By David Sell, Inquirer Staff Writer
Warren Buffett's annual shareholder letter is much followed by investors, and the latest version does not include Johnson & Johnson for the first time since 2005. The letter, released over the weekend, lists the companies in which the billionaire or Berkshire Hathaway, of which he is chairman, hold at least $1 billion in stock. With product recalls, patient lawsuits, and a federal investigation pending, Buffett was critical of J&J in February 2012 when he discussed his annual letter, telling CNBC that the health-care giant "obviously messed up in a lot of ways in the last few years.
BUSINESS
February 15, 2013 | By Rodrique Ngowi, Associated Press
BOSTON - Health care company Johnson & Johnson has been told to pay a teenager and her parents $63 million after she suffered a life-threatening drug reaction and lost most of her skin when she took a children's pain reliever nearly a decade ago. Johnson & Johnson and its Fort Washington-based McNeil-PPC Inc. subsidiary should pay Samantha Reckis and her parents a total of $109 million, including interest, a Plymouth Superior Court jury decided on...
BUSINESS
January 24, 2013 | By David Sell, Inquirer Staff Writer
NEW YORK - Pharmaceutical companies are pleased that health-care reform means more patients have insurance and will be encouraged to take their medicine to avoid costly hospitalizations. But, as Johnson & Johnson chief executive officer Alex Gorsky said Tuesday, drugmakers want private insurers or government programs such as Medicare and Medicaid to pay them for those drugs at a prices closer to their choosing. "Be aware," Gorsky said, that cost-containment efforts must "ensure we continue to reward innovation," or risk not having new drugs to treat health problems.
BUSINESS
October 30, 2012
Securities trades recently reported to the Securities and Exchange Commission by officers, directors and principal shareholders of corporations based or having sizable employment in the Philadelphia area. Titles are as reported to the SEC. Ace Ltd. John J. Lupica , officer, sold 3,466 shares at $82.01 Oct. 18 to Oct. 19, and now directly holds 112,347 shares. Air Products and Chemicals Inc. Lawrence S. Smith , director, bought 5,000 shares at $77.36 on Oct. 23, and now directly holds 9,850 shares.
NEWS
October 19, 2012 | By Ronnie Polaneczky, Daily News Columnist
THE DAY they opened The Laundry Cafe in Olney, owners Tyrone Akins and Brian Holland were approached by an older woman with an unexpected request. She had inspected the Laundromat's 150 high-end washers and dryers, granite-topped tables and coin-operated massage chairs. She had marveled at the low-fee computer stations, Starbucks coffee kiosk, digital jukebox, video games, free Wi-fi and flat-screen TVs. She made note of The Laundry Cafe's complimentary curbside assistance, first-load-free dryer service and bright community room where classes would be offered, free, on topics like how to start your own business.
BUSINESS
October 18, 2012 | By David Sell, Inquirer Staff Writer
Johnson & Johnson's third-quarter overall sales grew 6.5 percent and profits dropped 7.3 percent compared with the same period in 2011, as two of the health care giant's Philadelphia-area businesses were key elements in the good-and-bad financial picture. J&J is famous for Tylenol, Band-Aid bandages and shampoos, but this consumer segment is the last of the three divisions in sales, in part because the McNeil Consumer Healthcare facility in Fort Washington has been shut down since 2010, and the entire consumer unit is operating under legal restrictions.
1 | 2 | 3 | 4 | 5 | Next »
|
|
|
|
|